Skip to main content
SpringerLink
Log in

Optimaler Beginn der antiretroviralen Therapie bei HIV-positiven Patienten

Metaanalyse des When To Start Consortium

Timing of initiation of antiretroviral therapy in HIV-1-infected patients

Meta-analysis of the When To Start Consortium

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Strategies for Management of Antiretroviral Therapy (SMART) Study Group; El-Sadr WM, Lundgren JD, Seaton JD et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355: 2283–2296

    Article  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Medizinische Poliklinik der LMU, Pettenkoferstraße 8a, 80336, München, Deutschland

    F.-D. Goebel

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. F.-D. Goebel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F.-D. Goebel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goebel, FD., Nitschmann, S. Optimaler Beginn der antiretroviralen Therapie bei HIV-positiven Patienten. Internist 51, 539–541 (2010). https://doi.org/10.1007/s00108-010-2592-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-010-2592-7

Search

Navigation